SEI INVESTMENTS CO - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$534,805
-18.8%
47,879
+243.4%
0.00%0.0%
Q2 2022$659,000
-50.2%
13,942
-24.9%
0.00%
-66.7%
Q1 2022$1,323,000
-35.8%
18,570
-33.1%
0.00%
-25.0%
Q4 2021$2,061,000
+87.5%
27,756
+41.8%
0.00%
+100.0%
Q3 2021$1,099,000
+30.7%
19,578
+0.0%
0.00%0.0%
Q2 2021$841,000
-10.8%
19,575
-1.2%
0.00%0.0%
Q1 2021$943,000
+15.7%
19,817
-0.7%
0.00%0.0%
Q4 2020$815,000
-13.0%
19,965
-4.8%
0.00%
-33.3%
Q3 2020$937,000
-2.2%
20,975
+9.1%
0.00%0.0%
Q2 2020$958,000
+7.2%
19,222
+10.6%
0.00%0.0%
Q1 2020$894,000
-29.9%
17,378
-15.8%
0.00%
-25.0%
Q4 2019$1,275,000
+2.8%
20,6390.0%0.00%
+33.3%
Q3 2019$1,240,000
-28.8%
20,6390.0%0.00%
-50.0%
Q2 2019$1,742,000
-11.6%
20,6390.0%0.01%
-14.3%
Q1 2019$1,971,000
+48.4%
20,639
+29.3%
0.01%
+40.0%
Q4 2018$1,328,000
+0.5%
15,960
+1.5%
0.01%0.0%
Q3 2018$1,321,000
+402.3%
15,728
+593.5%
0.01%
+400.0%
Q2 2018$263,000
+68.6%
2,268
+18.0%
0.00%0.0%
Q1 2018$156,0001,922
+63966.7%
0.00%
Q4 2017$0
-100.0%
3
-100.0%
0.00%
-100.0%
Q3 2015$362,000
+5933.3%
10,024
+8930.6%
0.00%
Q4 2014$6,0001110.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders